| # | Drug | Count |
|---|---|---|
| 0 | LATANOPROST | 128 |
| 1 | ADALIMUMAB | 49 |
| 2 | BIMATOPROST | 33 |
| 3 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | 32 |
| 4 | BRIMONIDINE TARTRATE | 28 |
| 5 | ASPIRIN | 24 |
| 6 | BRINZOLAMIDE | 24 |
| 7 | ASPIRIN 325 MG | 22 |
| 8 | ASPIRIN 81 MG | 22 |
| 9 | PREDNISONE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEPEMOKIMAB | 1 | 0.0127 |
| 1 | LEVOBUNOLOL HYDROCHLORIDE | 1 | 0.0099 |
| 2 | APRACLONIDINE | 1 | 0.0090 |
| 3 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 4 | LATANOPROSTENE BUNOD | 7 | 0.0061 |
| 5 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 6 | METHAZOLAMIDE | 2 | 0.0058 |
| 7 | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION | 4 | 0.0050 |
| 8 | LATANOPROST OPHTHALMIC SOLUTION 0.005% | 3 | 0.0047 |
| 9 | DIFLUPREDNATE | 16 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostaglandin Analog [EPC] | 171 |
| 1 | Corticosteroid [EPC] | 81 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 49 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 39 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 31 |
| 5 | Insulin Analog [EPC] | 24 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 24 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 23 |
| 8 | Vitamin C [EPC] | 23 |
| 9 | Benzodiazepine [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 1 | Interleukin-17 Receptor A Antagonist [EPC] | 6 | 0.0029 |
| 2 | Nucleoside Analog Antifungal [EPC] | 3 | 0.0021 |
| 3 | Carbonic Anhydrase Inhibitor [EPC] | 39 | 0.0019 |
| 4 | Prostaglandin Analog [EPC] | 171 | 0.0018 |
| 5 | Quinolone Antimicrobial [EPC] | 9 | 0.0009 |
| 6 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 7 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 8 | Allylamine Antifungal [EPC] | 3 | 0.0004 |
| 9 | Osmotic Diuretic [EPC] | 2 | 0.0004 |